keyword
https://read.qxmd.com/read/35507180/protocol-for-the-detection-of-organoid-initiating-cell-activity-in-patient-derived-single-fallopian-tube-epithelial-cells
#61
JOURNAL ARTICLE
Liang Feng, Wenmei Yang, Hui Zhao, Jamie Bakkum-Gamez, Mark E Sherman, Nagarajan Kannan
Identification of serous tubal intraepithelial carcinomas (STIC) in the fallopian tubes of women who are carriers of germ line pathogenic variants in tubo-ovarian cancer predisposition genes (i.e., BRCA1 and BRCA2) has led to the hypothesis that many high-grade serous carcinomas (HGSC) arise from the fimbria of the fallopian tube. However, the primitive (stem and progenitor) tubal epithelial cells that give rise to STIC and HGSC have not been defined. Further, as putative HGSC precursors are discovered at salpingectomy, the natural history of such lesions is truncated at diagnosis...
2022: Methods in Molecular Biology
https://read.qxmd.com/read/35489439/racial-and-ethnic-differences-in-the-adoption-of-opportunistic-salpingectomy-for-ovarian-cancer-prevention-in-the-united-states
#62
JOURNAL ARTICLE
Pritesh S Karia, Yongmei Huang, Parisa Tehranifar, Kala Visvanathan, Jason D Wright, Jeanine M Genkinger
BACKGROUND: Clinicians in the United States have rapidly adopted opportunistic salpingectomy for ovarian cancer prevention. However, little is known about racial and ethnic differences in opportunistic salpingectomy adoption. Surgical innovations in gynecology may be adopted differentially across racial and ethnic groups, exacerbating current disparities in quality of care. OBJECTIVE: This study aimed to evaluate racial and ethnic differences in opportunistic salpingectomy adoption across inpatient and outpatient settings and assess the effect of national guidelines supporting opportunistic salpingectomy use on these differences...
August 2022: American Journal of Obstetrics and Gynecology
https://read.qxmd.com/read/35337614/stop-ovarian-cancer-stopovca-young-protocol-for-a-multicenter-follow-up-study-to-determine-the-long-term-effects-of-opportunistic-salpingectomy-on-age-at-menopause
#63
JOURNAL ARTICLE
Malou E Gelderblom, Joanna IntHout, Rosella P M G Hermens, Sjors F P J Coppus, Inge Ebisch, Alexandra A van Ginkel, Rafli van de Laar, Natascha de Lange, Marloes Maassen, Brenda Pijlman, Huberdina P M Smedts, M Caroline Vos, Catharina C M Beerendonk, Joanne A de Hullu, Jurgen M J Piek
BACKGROUND: Opportunistic salpingectomy comprises additional bilateral salpingectomy during abdominal surgery as a prophylactic method to reduce the risk of ovarian cancer. However, opportunistic salpingectomy may potentially damage (micro)blood circulation to the ovaries, resulting in earlier onset of menopause. PRIMARY OBJECTIVE: To evaluate the long-term effects of opportunistic salpingectomy on the onset of menopause in women who underwent sterilization through salpingectomy compared with a control group who underwent sterilization by tubal ligation or no surgery at all...
May 2022: Maturitas
https://read.qxmd.com/read/35323372/risk-reducing-options-for-high-grade-serous-gynecologic-malignancy-in-brca1-2
#64
JOURNAL ARTICLE
Lauren Clarfield, Laura Diamond, Michelle Jacobson
Ovarian cancer (OC) is the leading cause of death among women with gynecologic malignancy. Breast Cancer Susceptibility Gene 1 (BRCA 1) and Breast Cancer Susceptibility Gene 2 (BRCA 2) germline mutations confer an estimated 20 to 40 times increased risk of OC when compared to the general population. The majority of BRCA-associated OC is identified in the late stage, and no effective screening method has been proven to reduce mortality. Several pharmacologic and surgical options exist for risk-reduction of gynecologic malignancy in BRCA 1/2 mutation carriers...
March 21, 2022: Current Oncology
https://read.qxmd.com/read/35138400/outcomes-from-opportunistic-salpingectomy-for-ovarian-cancer-prevention
#65
JOURNAL ARTICLE
Gillian E Hanley, Celeste Leigh Pearce, Aline Talhouk, Janice S Kwon, Sarah J Finlayson, Jessica N McAlpine, David G Huntsman, Dianne Miller
Importance: Opportunistic salpingectomy (OS), which is the removal of fallopian tubes during hysterectomy or instead of tubal ligation without removal of ovaries, is recommended to prevent ovarian cancer, particularly serous ovarian cancer. However, the effectiveness of OS is still undetermined. Objective: To examine observed vs expected rates of ovarian cancer among individuals who have undergone OS. Design, Setting, and Participants: This is a population-based, retrospective cohort study of all individuals in British Columbia, Canada, who underwent OS or a control surgery (hysterectomy alone or tubal ligation) between 2008 and 2017, with follow-up until December 31, 2017...
February 1, 2022: JAMA Network Open
https://read.qxmd.com/read/35129467/opportunistic-salpingectomy-at-the-time-of-laparoscopic-cholecystectomy-for-ovarian-cancer-prevention-a-cost-effectiveness-analysis
#66
JOURNAL ARTICLE
Koji Matsuo, Ling Chen, Shinya Matsuzaki, Rachel S Mandelbaum, Katharine M Ciesielski, Jack P Silva, Maximilian Klar, Lynda D Roman, Melissa K Accordino, Alexander Melamed, Elena Elkin, Dawn L Hershman, Jason D Wright
OBJECTIVE: To perform a cost-effectiveness analysis to examine the utility and effectiveness of opportunistic salpingectomy (OS) performed at the time of elective cholecystectomy (LAP-CHOL). SUMMARY BACKGROUND DATA: OS has been adopted as a strategy to reduce the risk of ovarian cancer in women undergoing hysterectomy and tubal sterilization, although the procedure is rarely performed as a risk reducing strategy during other abdominopelvic procedures. METHODS: A decision model was created to examine women 40, 50, and 60 years of age undergoing LAP-CHOL with or without OS...
January 27, 2022: Annals of Surgery
https://read.qxmd.com/read/35114854/ovarian-cancer-surgery-in-germany-an-analysis-of-the-nationwide-hospital-file-2005-2015
#67
JOURNAL ARTICLE
Pietro Trocchi, Pawel Mach, Karl Rainer Kimmig, Andreas Stang
OBJECTIVES: Nationwide hospitalization data on the surgical management of ovarian cancer are scant. We assessed type of surgery, surgical approach, length of stay, surgery-related complications and in-hospital mortality among women with ovarian cancer in Germany. We analyzed nationwide hospitalization file of 2005 through 2015 including 77,589 ovarian cancer-related hospitalizations associated with ovarian surgery. METHODS: We calculated the relative frequency of the surgical approaches by type of surgery and calendar time...
January 2022: Women's Health
https://read.qxmd.com/read/35020193/opportunistic-salpingectomy-may-reduce-ovarian-cancer-risk
#68
COMMENT
Mike Fillon
No abstract text is available yet for this article.
March 2022: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/34997316/cancer-worry-among-brca1-2-pathogenic-variant-carriers-choosing-surgery-to-prevent-tubal-ovarian-cancer-course-over-time-and-associated-factors
#69
MULTICENTER STUDY
Majke H D van Bommel, Miranda P Steenbeek, Joanna IntHout, Rosella P M G Hermens, Nicoline Hoogerbrugge, Marline G Harmsen, Helena C van Doorn, Marian J E Mourits, Marc van Beurden, Ronald P Zweemer, Katja N Gaarenstroom, Brigitte F M Slangen, Monique M A Brood-van Zanten, M Caroline Vos, Jurgen M Piek, Luc R C W van Lonkhuijzen, Mirjam J A Apperloo, Sjors F P J Coppus, Judith B Prins, José A E Custers, Joanne A de Hullu
OBJECTIVE: High cancer risks, as applicable to BRCA1 and BRCA2 pathogenic variant (PV) carriers, can induce significant cancer concerns. We examined the degree of cancer worry and the course of this worry among BRCA1/2-PV carriers undergoing surgery to prevent ovarian cancer, and identified factors associated with high cancer worry. METHODS: Cancer worry was evaluated as part of the multicentre, prospective TUBA-study (NCT02321228) in which BRCA1/2-PV carriers choose either novel risk-reducing salpingectomy with delayed oophorectomy or standard risk-reducing salpingo-oophorectomy...
April 2022: Supportive Care in Cancer
https://read.qxmd.com/read/34900612/pyomyoma-mimicking-tubo-ovarian-abscess-two-case-reports
#70
Kyoko Oshina, Rie Ozaki, Jun Kumakiri, Keisuke Murakami, Yu Kawasaki, Mari Kitade, Atsuo Itakura
Pyomyoma is an extremely rare complication, defined as an infection of a uterine leiomyoma. We describe two cases of pyomyoma that were initially considered to be tubo-ovarian abscesses but were later diagnosed as pyomyomas and managed with laparoscopic surgery. Case 1 was a 26-year-old nulliparous woman who was previously diagnosed with bilateral endometriomas and presented to the hospital with lower abdominal pain. Magnetic resonance imaging revealed bilateral endometrial cysts and a 4-cm mass consistent with a tubo-ovarian abscess...
January 2022: Case Reports in Women's Health
https://read.qxmd.com/read/34873108/factors-affecting-surgical-decision-making-in-carriers-of-brca1-2-pathogenic-variants-undergoing-risk-reducing-surgery-at-a-dedicated-hereditary-ovarian-cancer-clinic
#71
JOURNAL ARTICLE
Michelle R Jacobson, Melissa Walker, Gabrielle E V Ene, Courtney Firestone, Marcus Q Bernardini, Lisa Allen, Ella Huszti, Mara Sobel
OBJECTIVE: Women with germline BRCA1/2 pathogenic variants have a significantly elevated lifetime risk of ovarian and fallopian tube cancer. Bilateral salpingo-oophorectomy (RRSO) is associated with a 90% reduction in the development of tubal and ovarian cancer. At our tertiary hospital, we have a dedicated clinic where women predisposed to hereditary ovarian/tubal cancer receive counseling on reproduction, risk reduction, surgical prophylaxis, and menopausal aftercare. The objective of this study was to evaluate the choices that Canadian women with BRCA1/2 pathogenic variants make regarding ovarian cancer risk reduction within this highly specialized multidisciplinary clinic...
December 6, 2021: Menopause: the Journal of the North American Menopause Society
https://read.qxmd.com/read/34870544/efficacy-and-safety-of-sterilisation-procedures-to-reduce-the-risk-of-epithelial-ovarian-cancer-a-systematic-review-comparing-salpingectomy-with-tubal-ligation
#72
JOURNAL ARTICLE
Leonidas Magarakis, Annika Idahl, Charlotte Särnqvist, Annika Strandell
PURPOSE: The objective of this systematic review is to evaluate current literature comparing salpingectomy for sterilisation with tubal ligation, regarding the effectiveness and safety, and assess the certainty of evidence. MATERIALS AND METHODS: PubMed, Cochrane, and Embase databases were searched. Randomised (RCT) and observational studies were included. Articles were quality assessed and data extracted by two independent authors. Certainty of evidence was assessed using GRADE...
June 2022: European Journal of Contraception & Reproductive Health Care
https://read.qxmd.com/read/34850262/recommendations-for-diagnosing-stic-a-systematic-review-and-meta-analysis
#73
REVIEW
Joep M A Bogaerts, Miranda P Steenbeek, Majke H D van Bommel, Johan Bulten, Jeroen A W M van der Laak, Joanne A de Hullu, Michiel Simons
Our understanding of the oncogenesis of high-grade serous cancer of the ovary and its precursor lesions, such as serous tubal intraepithelial carcinoma (STIC), has significantly increased over the last decades. Adequate and reproducible diagnosis of these precursor lesions is important. Diagnosing STIC can have prognostic consequences and is an absolute requirement for safely offering alternative risk reducing strategies, such as risk reducing salpingectomy with delayed oophorectomy. However, diagnosing STIC is a challenging task, possessing only moderate reproducibility...
December 1, 2021: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/34705269/a-retrospective-cohort-study-of-tubal-occlusion-or-salpingectomy-for-permanent-contraception-in-australia
#74
JOURNAL ARTICLE
Tanja Baltus, James Brown, Supuni Kapurubandara
BACKGROUND: Laparoscopic permanent contraception was previously accomplished most commonly using tubal occlusion procedures. Bilateral salpingectomy (BS) has recently been introduced as an alternative due to possibly superior contraception and greater protection against ovarian cancer. AIMS: The aim of this study is to assess uptake, feasibility and perioperative outcomes of laparoscopic BS as an alternative to tubal occlusion in Australia. MATERIALS AND METHODS: A retrospective review of permanent female contraception at two Australian hospitals from January 2014 through December 2020 was performed...
April 2022: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/34555878/survey-acceptability-of-opportunistic-bilateral-salpingectomy-in-flanders
#75
JOURNAL ARTICLE
A S Maryns, A Makar, T Hamerlynck, B De Vree, P Tummers, W A A Tjalma
Background: The VVOG (Flemish Society of Obstetrics and Gynaecology) published a consensus statement promoting opportunistic bilateral salpingectomy (OBS). Objectives: The aim of the study was to obtain insight into the current opinion and general practice of Flemish gynaecologists to counsel and perform OBS. Materials and Methods: A questionnaire was distributed to Flemish gynaecologists three months following publication. Main outcome measures: The drawbacks and incentives to counsel and perform OBS were questioned...
September 2021: Facts, Views & Vision in ObGyn
https://read.qxmd.com/read/34554566/barriers-to-salpingectomy-for-permanent-contraception-a-qualitative-study-with-obstetricians-and-gynaecologists
#76
JOURNAL ARTICLE
Helena M Obermair, Georgia Muir, Gregory B Gard
Consideration of risk-reducing bilateral salpingectomy has been recommended instead of tubal occlusive procedures for female sterilisation due to the role of the Fallopian tubes in the aetiology of serous ovarian malignancies. This study identified barriers to performing salpingectomy for permanent contraception. Twenty-two semi-structured interviews were conducted with Australian gynaecologists, and transcripts analysed qualitatively. Barriers to performing bilateral salpingectomy included: (a) patient factors (younger age and risk of regret); (b) operative complexity and complications (particularly risk of bleeding); (c) surgeon factors (lack of awareness of guidelines supporting salpingectomy; less comfort with laparoscopic surgery); and (d) practical system challenges (including cost and equipment availability)...
December 2021: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://read.qxmd.com/read/34536392/primary-prevention-of-ovarian-cancer-a-patient-decision-aid-for-opportunistic-salpingectomy
#77
JOURNAL ARTICLE
Laura A M van Lieshout, Malou E Gelderblom, Joanne A de Hullu, Regina The, Alexandra A van Ginkel, Anke J M Oerlemans, Kirsten M W H Smeets, Malou P H Schreurs, Jurgen M J Piek, Rosella P M G Hermens
BACKGROUND: The discovery of the fallopian tube epithelium as the origin of high-grade serous ovarian cancer has brought a new option for ovarian cancer prevention. The fallopian tubes have no known function after completion of childbearing and can be removed to reduce the lifetime risk of ovarian cancer. Although the lifetime risk in the general population does not justify preventive surgery in itself, salpingectomy can be performed during abdominal surgery for other indications, also known as an opportunistic salpingectomy...
February 2022: American Journal of Obstetrics and Gynecology
https://read.qxmd.com/read/34499134/cost-effectiveness-analysis-of-genotype-specific-surveillance-and-preventive-strategies-for-gynecologic-cancers-among-women-with-lynch-syndrome
#78
JOURNAL ARTICLE
Jason D Wright, Elisabeth R Silver, Sarah Xinhui Tan, Chin Hur, Fay Kastrinos
Importance: With the expansion of multigene testing for cancer susceptibility, Lynch syndrome (LS) has become more readily identified among women. The condition is caused by germline pathogenic variants in DNA mismatch repair genes (ie, MLH1, MSH2, MSH6, and PMS2) and is associated with high but variable risks of endometrial and ovarian cancers based on genotype. However, current guidelines on preventive strategies are not specific to genotypes. Objective: To assess the cost-effectiveness of genotype-specific surveillance and preventive strategies for LS-associated gynecologic cancers, including a novel, risk-reducing surgical approach associated with decreased early surgically induced menopause...
September 1, 2021: JAMA Network Open
https://read.qxmd.com/read/34456057/evaluation-of-a-patient-decision-aid-for-brca1-2-pathogenic-variant-carriers-choosing-an-ovarian-cancer-prevention-strategy
#79
JOURNAL ARTICLE
Miranda P Steenbeek, Majke H D van Bommel, Marline G Harmsen, Nicoline Hoogerbrugge, Helena C van Doorn, José H M Keurentjes, Marc van Beurden, Ronald P Zweemer, Katja N Gaarenstroom, Charlotte G J Penders, Monique M A Brood-van Zanten, M Caroline Vos, Jurgen M Piek, Luc R C W van Lonkhuijzen, Mirjam J A Apperloo, Sjors F P J Coppus, Joanna IntHout, Joanne A de Hullu, Rosella P M G Hermens
OBJECTIVE: Risk-reducing surgery is advised to BRCA1/2 pathogenic variant (PV) carriers around the age of 40 years to reduce ovarian cancer risk. In the TUBA-study, a multicenter preference study (NCT02321228), BRCA1/2-PV carriers are offered a choice: the standard strategy of risk-reducing salpingo-oophorectomy or the novel strategy of risk-reducing salpingectomy with delayed oophorectomy. We evaluated feasibility and effectiveness of a patient decision aid for this choice. METHODS: Premenopausal BRCA1/2-PV carriers were counselled for risk-reducing surgical options in the TUBA-study; the first cohort was counselled without and the second cohort with decision aid...
August 26, 2021: Gynecologic Oncology
https://read.qxmd.com/read/34413116/uptake-and-predictors-of-opportunistic-salpingectomy-for-ovarian-cancer-risk-reduction-in-the-united-states
#80
JOURNAL ARTICLE
Pritesh S Karia, Corinne E Joshu, Kala Visvanathan
Evidence suggesting that high-grade serous ovarian cancers originate in the fallopian tubes has led to the emergence of opportunistic salpingectomy (OS) as an approach to reduce ovarian-cancer risk. In the U.S., some national societies now recommend OS in place of tubal ligation for sterilization or during a benign hysterectomy in average-risk women. However, limited data exist on the dissemination of OS in clinical practice. We examined the uptake and predictors of OS in a nationwide sample of inpatient and outpatient claims ( N = 48,231,235) from 2010 to 2017...
December 2021: Cancer Prevention Research
keyword
keyword
23408
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.